These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 328399)

  • 41. Carbohydrate metabolism in C3H/HeJ (nonresponder) mice during endotoxic shock.
    McCallum RE; Pontious ML
    Adv Shock Res; 1979; 2():113-27. PubMed ID: 400573
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunogenic dialyzable factor derived from a ribosomal fraction of Salmonella typhimurium. I. Preparation of the protective dialyzable factor from the ribosomal fraction by the freeze-thaw procedure.
    Kita E; Matsuura H; Masuda S; Tomihata S; Kashiba S
    Microbiol Immunol; 1983; 27(1):7-24. PubMed ID: 6346023
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dissociation of innate susceptibility to Salmonella infection and endotoxin responsiveness in C3HeB/FeJ mice and other strains in the C3H lineage.
    Eisenstein TK; Deakins LW; Killar L; Saluk PH; Sultzer BM
    Infect Immun; 1982 May; 36(2):696-703. PubMed ID: 7044974
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protection against mouse typhoid by artificial Salmonella vaccines.
    Svenson SB; Lindberg AA
    Scand J Infect Dis Suppl; 1980; Suppl 24():210-5. PubMed ID: 6163199
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of immunity to infection with Salmonella typhimurium in outbred mice. I. Requirement of the antibody to non-O antigen for protection in mice that are not protected by the RNA-rich vaccine.
    Kita E; Nishi K; Emoto M; Katsui N; Yasui K; Yasui K; Kashiba S
    Immunology; 1987 Aug; 61(4):535-41. PubMed ID: 2450832
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detoxified bacterial endotoxins. I. Preparation and biological properties of an acetylated crude endotoxin from Salmonella typhimurium.
    Martin WJ; Marcu S
    J Bacteriol; 1966 Apr; 91(4):1453-9. PubMed ID: 5326109
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunogenicity of ribosomal preparations from Neisseria gonorrhoeae.
    Cooper MD; Tewari RP; Bowser DV
    Infect Immun; 1980 Apr; 28(1):92-100. PubMed ID: 6769823
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protection and immune responses induced by attenuated Salmonella typhimurium UK-1 strains.
    Zhang X; Kelly SM; Bollen W; Curtiss R
    Microb Pathog; 1999 Mar; 26(3):121-30. PubMed ID: 10089152
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit opsonizing antibodies that enhance phagocytosis.
    Jörbeck HJ; Svenson SB; Lindberg AA
    Infect Immun; 1981 May; 32(2):497-502. PubMed ID: 7019072
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral adjuvants enhance IgA responses to Streptococcus mutans.
    Michalek SM; Morisaki I; Gregory RL; Kiyono H; Hamada S; McGhee JR
    Mol Immunol; 1983 Sep; 20(9):1009-18. PubMed ID: 6358863
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detoxified bacterial endotoxns. II. Preparation and biological properties of chemically modified crude endotoxins from Salmonella typhimurium.
    Martin WJ; Marcus S
    J Bacteriol; 1966 May; 91(5):1750-8. PubMed ID: 4287071
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differences in delayed-type hypersensitivity responses in various mouse strains in the C3H lineage infected with Salmonella typhimurium, strain SL3235.
    Killar LM; Eisenstein TK
    J Immunol; 1984 Sep; 133(3):1190-6. PubMed ID: 6379046
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of activated macrophages in C3H/HeJ mice by avirulent Salmonella.
    Schafer R; Nacy CA; Eisenstein TK
    J Immunol; 1988 Mar; 140(5):1638-44. PubMed ID: 3279120
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monoclonal antibodies to salmonella lipopolysaccharide: functional analysis of anti-lipid A antibodies.
    Ward DC; Michalek SM; McGhee JR
    Clin Exp Immunol; 1988 Apr; 72(1):157-63. PubMed ID: 3293850
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Formation of interferon-gamma and tumor necrosis factor in mice during Salmonella typhimurium infection.
    Kumazawa Y; Freudenberg MA; Hausmann C; Meding-Slade S; Langhorne J; Galanos C
    Pathobiology; 1991; 59(3):194-6. PubMed ID: 1909143
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Macrophage defect and inflammatory cell recruitment dysfunction in Salmonella susceptible C3H/HeJ mice.
    Weinstein DL; Lissner CR; Swanson RN; O'Brien AD
    Cell Immunol; 1986 Oct; 102(1):68-77. PubMed ID: 3542230
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gamma interferon production in endotoxin-responder and -nonresponder mice during infection.
    Freudenberg MA; Kumazawa Y; Meding S; Langhorne J; Galanos C
    Infect Immun; 1991 Oct; 59(10):3484-91. PubMed ID: 1910003
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determinants of immunity to murine salmonellosis: studies involving immunization with lipopolysaccharide-lipid A-associated protein complexes in C3H/HeJ mice.
    Killion JW; Morrison DC
    FEMS Microbiol Immunol; 1988 Jan; 1(1):41-53. PubMed ID: 3272826
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Two Novel
    Zhao X; Dai Q; Jia R; Zhu D; Liu M; Wang M; Chen S; Sun K; Yang Q; Wu Y; Cheng A
    Front Cell Infect Microbiol; 2017; 7():391. PubMed ID: 28929089
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protective immunities induced by porins from mutant strains of Salmonella typhimurium.
    Matsui K; Arai T
    Microbiol Immunol; 1990; 34(11):917-27. PubMed ID: 1965322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.